Lars H. Ehlers

Arhus, 8000, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 101 publications

The Epidemiological and Economic Burden of Vaccine-Preventable Respiratory Diseases Among Adults Aged 65 Years and Older in the Nordic Countries.

The Epidemiological and Economic Burden of Vaccine-Preventable Respiratory Diseases Among Adults Aged 65 Years and Older in the Nordic Countries.

Journal: Vaccines

Published: July 02, 2026

Impact of Increased SGLT2 Inhibitor Uptake in CKD Management in Denmark: Modeling National Patient Benefits and Cost Savings.

Impact of Increased SGLT2 Inhibitor Uptake in CKD Management in Denmark: Modeling National Patient Benefits and Cost Savings.

Journal: Kidney medicine

Published: June 01, 2026

Early health economic assessment of eLi12, a new method to estimate 12-hour lithium levels when blood sampling deviates from 12 hours.

Early health economic assessment of eLi12, a new method to estimate 12-hour lithium levels when blood sampling deviates from 12 hours.

Journal: Acta neuropsychiatrica

Published: April 06, 2026

Early health economic assessment of eLi12, a new method to estimate 12-h lithium levels when blood sampling deviates from 12 h.

Early health economic assessment of eLi12, a new method to estimate 12-h lithium levels when blood sampling deviates from 12 h.

Journal: Acta neuropsychiatrica

Published: April 06, 2026

Cost-Effectiveness of Venetoclax-Based Treatment in Treatment-Naïve Fit Patients With CLL Without TP53 Aberrations.

Cost-Effectiveness of Venetoclax-Based Treatment in Treatment-Naïve Fit Patients With CLL Without TP53 Aberrations.

Journal: European journal of haematology

Published: December 05, 2025

Cost-Effectiveness of Venetoclax-Based Treatment in Treatment-Naïve Fit Patients With CLL Without TP53 Aberrations.

Cost-Effectiveness of Venetoclax-Based Treatment in Treatment-Naïve Fit Patients With CLL Without TP53 Aberrations.

Journal: European journal of haematology

Published: December 05, 2025

Healthcare Costs Associated With Anabolic Steroid Use: A Cohort Study.

Healthcare Costs Associated With Anabolic Steroid Use: A Cohort Study.

Journal: Scandinavian journal of medicine & science in sports

Published: August 12, 2025

Increasing patient access to faecal microbiota transplantation with remote delivery: a cost analysis of outpatient versus home-based treatment.

Increasing patient access to faecal microbiota transplantation with remote delivery: a cost analysis of outpatient versus home-based treatment.

Journal: Health economics review

Published: March 06, 2025

Cost-Effectiveness of Hospital-at-Home and Fecal Microbiota Transplantation in Treating Older Patients With Clostridioides difficile.

Cost-Effectiveness of Hospital-at-Home and Fecal Microbiota Transplantation in Treating Older Patients With Clostridioides difficile.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: November 08, 2024

Evaluating Cost-Effectiveness of Antiretroviral Therapy over Time: A Cohort and Cost-Effectiveness Study.

Evaluating Cost-Effectiveness of Antiretroviral Therapy over Time: A Cohort and Cost-Effectiveness Study.

Journal: PharmacoEconomics - open

Published: July 15, 2024

Cost-effectiveness of faecal microbiota transplantation compared with vancomycin monotherapy for early Clostridioides difficile infection: economic evaluation alongside a randomized controlled trial.

Cost-effectiveness of faecal microbiota transplantation compared with vancomycin monotherapy for early Clostridioides difficile infection: economic evaluation alongside a randomized controlled trial.

Journal: The Journal of hospital infection

Published: June 26, 2024

Global barriers to decision makers for prioritizing interventions for obesity.

Global barriers to decision makers for prioritizing interventions for obesity.

Journal: International journal of obesity (2005)

Published: June 24, 2024

Showing 1-12 of 101

Last Updated: 09/26/2026